Thank you to our major corporate sponsors

The following sponsors supported the programs and services of the American Kidney Fund with generous contributions of $5,000 or more in 2020.

($500,000+)

AstraZeneca Pharmaceuticals LP
GlaxoSmithKline

($100,000–$499,999)

Akebia Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Amgen USA
Cara Therapeutics
DaVita Healthcare Partners, Inc
FMC Renal Pharmaceuticals
Horizon Therapeutics
Otsuka America Pharmaceutical Inc.
Sanofi-Genzyme
Tricida Inc
Vertex, Inc.

($50,000–$99,999)

Abbott Nutrition
Alexion Pharmaceuticals, Inc.
Ardelyx, Inc.
Rockpointe Corporation
Satellite Healthcare Inc
Truist Foundation - formerly Suntrust

($25,000–$49,999)

Gentian
Relypsa, Inc.
Right Advisory LLC
Travere

($5,000–$24,999)

American Society of Nephrology
Apellis Pharmaceuticals, Inc.
Aurinia
Biotechnology Innovation Organization (BIO)
ColorNet Printing & Graphics
Dime Community Bank
EventEQ
Federal Street Strategies LLC
Flushing Bank
Fresenius Medical Care
Institute for Advanced Clinical Trials for Children
Interactive Strategies
Jaspan Schlesinger LLP
JPA Health Communications
King & Spalding LLP
Latham & Watkins
Mallinckrodt Inc.
Mercury Public Affairs
Natera
National Renal Administrators Association
Northleaf Capital Partners
Omeros Corporation
OPKO Health - Renal Division
Orases
PhRMA
PROTEK Consulting
RKD Group
Rockwell Medical Technologies Inc
Satter Investment Management
SPG Fiduciary Partners of Raymond James
Spherix Global Insights
SplitOak Strategies LLC
The Cooking Doc, LLC
The Meltzer Group NFP
Vendorin
York Studios

Pharmaceutical Funding

  • The total pharmaceutical revenue including donated product is $5,361,700
  • The percentage of revenue from pharmaceutical companies is 1.59%

Note: Compliance with the U.S. Department of Health and Human Services Office of the Inspector General Opinion 97-1, under which the HIPP program operates, prohibits HIPP (Health Insurance Premium Program) donors to be included in this list.